title: Heat-killed and live Lactobacillus reuteri GMNL-263 exhibit similar effects on improving metabolic functions in high-fat diet-induced obese rats.
abstract: Our objective was to investigate and compare the effects of heat-killed (HK) and live Lactobacillus reuteri GMNL-263 (Lr263) on insulin resistance and its related complications in high-fat diet (HFD)-induced rats. Male Sprague-Dawley rats were fed with a HFD with either HK or live Lr263 for 12 weeks. The increases in the weight gain, serum glucose, insulin, and lipid profiles in the serum and liver observed in the HFD group were significantly reduced after HK or live Lr263 administration. Feeding HK or live Lr263 reversed the decreased number of probiotic bacteria and increased the number of pathogenic bacteria induced by high-fat treatment. The decreased intestinal barrier in the HFD group was markedly reversed by HK or live Lr263 treatments. The elevations of pro-inflammatory associated gene expressions in both adipose and hepatic tissues by high-fat administration were markedly decreased by HK or live Lr263 treatments. The increased macrophage infiltration noticed in adipose tissue after high-fat treatment was effectively suppressed by HK or live Lr263 consumption. The insulin resistance associated gene expressions in both adipose and hepatic tissues, which were downregulated in the HFD group, were markedly enhanced after HK or live Lr263 administration. HK or live Lr263 consumption significantly decreased hepatic lipogenic gene expressions stimulated by high-fat treatment. Administration of HK or live Lr263 significantly reduced hepatic oil red O staining and ameliorated the hepatic steatosis observed in high-fat treated rats. Our data suggested that similar to live Lr263, HK Lr263 exerted significant effects on attenuating obesity-induced metabolic abnormalities by reducing insulin resistance and hepatic steatosis formation.
authors.affiliation: Department of Medical Laboratory Science and Biotechnology, Kaohsiung Medical University, Kaohsiung, Taiwan. m785034@kmu.edu.tw.
authors.forename: Feng-Ching
authors.initials: FC
authors.lastname: Hsieh
authors.forename: Cheng-Che E
authors.initials: CC
authors.lastname: Lan
authors.forename: Tsui-Yin
authors.initials: TY
authors.lastname: Huang
authors.forename: Kuan-Wei
authors.initials: KW
authors.lastname: Chen
authors.forename: Chee-Yin
authors.initials: CY
authors.lastname: Chai
authors.forename: Wan-Tzu
authors.initials: WT
authors.lastname: Chen
authors.forename: Ai-Hui
authors.initials: AH
authors.lastname: Fang
authors.forename: Yi-Hsing
authors.initials: YH
authors.lastname: Chen
authors.forename: Ching-Shuang
authors.initials: CS
authors.lastname: Wu
mesh_terms: D050154:Adiposity / Q000235:genetics; D000818:Animals; D001391:Azo Compounds; D001419:Bacteria / Q000472:pathogenicity; D001786:Blood Glucose; D001835:Body Weight; D004269:DNA, Bacterial / Q000032:analysis; D059305:Diet, High-Fat / Q000009:adverse effects*; D005234:Fatty Liver / Q000473:pathology / Q000517:prevention & control; D005243:Feces / Q000382:microbiology; D000069196:Gastrointestinal Microbiome / Q000235:genetics; D015870:Gene Expression; D005951:Glucose Tolerance Test; D006358:Hot Temperature; D007150:Immunohistochemistry; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance; D052200:Limosilactobacillus reuteri / Q000235:genetics; D008055:Lipids / Q000097:blood; D050155:Lipogenesis / Q000235:genetics; D008264:Macrophages / Q000276:immunology; D008297:Male; D023421:Models, Animal; D009765:Obesity / Q000178:diet therapy* / Q000208:ethnology / Q000378:metabolism*; D019936:Probiotics / Q000627:therapeutic use*; D051381:Rats; D017207:Rats, Sprague-Dawley; D015430:Weight Gain
chemical_list: D001391:Azo Compounds; D001786:Blood Glucose; D004269:DNA, Bacterial; D007328:Insulin; D008055:Lipids; C011049:oil red O